TRPM7 and metastatic neoplasm: Elevated expression of TRPM7 in metastatic tumors (n = 16) as compared to that in non-metastatic pancreatic adenocarcinoma (stages I, II, and III combined, n = 266) was present but statistically marginal (P = 0.1).